OKOMERA

okomera-logo

Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies. It pioneers automation and miniaturization of personalized tumor biopsy studies. This technology was invented and patented by Okomera's co-founders at Ecole Polytechnique. Aimee Wessel, Raphaël Tomas, Charles Baroud, and Sandra Jernström founded the Paris, Ile-de-France-based company in 2020.

#SimilarOrganizations #People #Financial #Website #More

OKOMERA

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2020-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.okomera.com

Total Employee:
1+

Status:
Active

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Typekit OVH Squarespace


Similar Organizations

apeiron-biologics-logo

Apeiron Biologics

Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.

aukera-therapeutics-logo

Aukera Therapeutics

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

t3-pharmaceuticals-logo

T3 Pharmaceuticals

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.


Current Advisors List

charles-baroud_image

Charles Baroud Advisor @ Okomera
Advisor

Current Employees Featured

raphaël-tomasi_image

Raphaël Tomasi
Raphaël Tomasi Co-founder, Chief Technology Officer @ Okomera
Co-founder, Chief Technology Officer
2020-07-01

sandra-jernström_image

Sandra Jernström
Sandra Jernström Co-founder, Chief Scientific Officer @ Okomera
Co-founder, Chief Scientific Officer
2020-07-01

charles-baroud_image

Charles Baroud
Charles Baroud Co-Founder and scientific advisor @ Okomera
Co-Founder and scientific advisor
2020-01-01

aimee-wessel_image

Aimee Wessel
Aimee Wessel Co-founder and Chief Executive Officer @ Okomera
Co-founder and Chief Executive Officer
2020-07-01

Founder


aimee-wessel_image

Aimee Wessel

charles-baroud_image

Charles Baroud

raphaël-tomasi_image

Raphaël Tomasi

sandra-jernström_image

Sandra Jernström

Investors List

agoranov_image

AGORANOV

AGORANOV investment in Non Equity Assistance - Okomera

Official Site Inspections

http://www.okomera.com

  • Host name: 198.202.211.1
  • IP address: 198.202.211.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Okomera"

Okomera - Crunchbase Company Profile & Funding

Organization. Okomera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Okomera is a …See details»

Okomera - Find the best cancer treatment for every patient

Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, …See details»

Okomera - LinkedIn

Okomera | 7,993 followers on LinkedIn. Automated 3D organoid screening technology | We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug …See details»

Okomera 2025 Company Profile: Valuation, Funding & Investors

Okomera General Information Description. Developer of medical technologies designed to accelerate the development of modern cancer therapies with microfluidic 3D cellular assays. …See details»

Okomera - Contacts, Employees, Board Members, Advisors & Alumni

Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience …See details»

Okomera - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 6, 2025 Okomera - Developer of a device for in vitro cancer testing using a microfluidic chip. Raised a total funding of $11.2M over 1 round from 5 investors. Founded by Aimee Wessel, …See details»

Okomera Company Profile: Overview and Full News Analysis

Okomera is a company based in Ile-de-France that specializes in revolutionizing drug discovery and personalized medicine through their innovative technology. They offer an automated 3D …See details»

Okomera - Funding, Financials, Valuation & Investors - Crunchbase

Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How much …See details»

Why Okomera will be a game-changer in personalized …

Dec 21, 2023 Okomera is a French biotech specialized in the fight against cancer. With the idea of revolutionizing cancer diagnostic devices, the startup enables the creation of replicas of cancerous tumors on ...See details»

Okomera - VentureRadar

Okomera revolutionizes cancer treatment with its automated 3D organoid screening technology. By integrating standard assays on chip, such as CRISPR and T-cell cytotoxicity, Okomera …See details»

Okomera | Biotech Careers

Automated 3D organoid screening technology that integrates standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and …See details»

Okomera - Products, Competitors, Financials, Employees, …

Okomera develops personalized cancer treatment technologies within the biotechnology sector. Use the CB Insights Platform to explore Okomera's full profile. Okomera - Products, …See details»

Okomera raises €10.2m to develop personalized medicine

Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, …See details»

Okomera - News & Articles

Jan 27, 2025 Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies …See details»

Okomera : les organoïdes pour accélérer la découverte de …

Okomera a annoncé le 16 octobre 2024 l’obtention d’une subvention d’1,5 M€ de Bpifrance, à cheval entre subvention et avance récupérable. Ce financement va permettre de développer …See details»

Okomera lève 10,2 M€ pour prédire les traitements du cancer

Jan 24, 2024 Fondée en 2020 à Paris, Okomera se consacre au développement d'une technologie avancée pour évaluer l'efficacité des traitements contre le cancer. Aujourd’hui …See details»

Okomera - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»

Okomera to Present Automated Desktop Organoid Screening …

PARIS, Jan. 28, 2025 /PRNewswire/ -- Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San …See details»

Empowering Personalized Cancer Treatments: Okomera - Medium

Okomera is developing a revolutionary cancer diagnostic machine that enables testing of oncology drugs directly on solid tumor biopsies. Our patented droplet microfluidic technology …See details»

Okomera announces 10 million € fundraise on French TV

Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, …See details»

linkstock.net © 2022. All rights reserved